LKFT
Galapagos N.V. Sponsored ADR
NASDAQ · Healthcare · Biotechnology · US
$28.49
−1.83%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.82
- Revenue estimate
- $8.9M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.24
- EPS estimate
- -$0.15
- Revenue actual
- $14.0M
- Revenue estimate
- $14.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +32.2%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $26
- PT range
- $26 – $26
- Analysts
- 2
0 Buy2 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026